CTLT Profile
Catalent, Inc., and its subsidiaries are renowned for their global leadership in developing and manufacturing advanced solutions across a spectrum of pharmaceuticals, biologics, and consumer health products. Founded in 2007 and headquartered in Somerset, New Jersey, Catalent operates through four key segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services.
The Biologics segment specializes in biologic cell-line development, manufacturing for cell therapy and gene therapy products, and formulation services for parenteral dose forms. This includes vials, prefilled syringes, and cartridges, alongside comprehensive analytical testing capabilities. In the Softgel and Oral Technologies segment, Catalent provides formulation, development, and manufacturing services for soft capsules used in prescription drugs, OTC medications, dietary supplements, cosmetics, and animal health preparations.
Catalent’s Oral and Specialty Delivery segment offers a diverse portfolio of formulation and development technologies, encompassing pre-clinical screening, analytical development, and manufacturing services adhering to current good manufacturing practices (cGMP). Additionally, its Clinical Supply Services segment supports pharmaceutical and biotechnology companies with end-to-end solutions for clinical trials, including manufacturing, packaging, storage, distribution, and demand-led clinical supply services through FastChain. Catalent serves a broad client base spanning pharmaceuticals, biotechnology, consumer health, animal health, medical devices, and cosmetics industries worldwide, leveraging its extensive expertise and innovative capabilities to advance healthcare solutions globally.
|
